[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370702-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370702-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","genomic-landscape-of-virus-associated-cancers","Genomic landscape of virus-associated cancers","","Comparative genomic analysis across nine cancers linked to five oncogenic viruses identifies distinct patterns between virus-positive and virus-negative tumors. Using 1971 tumor genomes, the study finds virus-positive cases with lower somatic burden, different mutational signatures, and recurrent driver gene changes. Virus-positive tumors show reduced TP53 and CDKN2A alterations and specific 9p21.3/CDKN2A-CDKN1A deletions, alongside increased DDX3X and EIF4A1 mutations. Clinical-trial analysis of PD-(L)1 inhibitors links virus positivity to higher treatment response, especially in gastric cancer and head-and-neck squamous cell carcinoma, with increased CD8+ T-cell infiltration and TCR clonal selection.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/genomic-landscape-of-virus-associated-cancers/370702/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/genomic-landscape-of-virus-associated-cancers/370702.png","ImageObject",300,407,{"name":42,"@type":43},"Chumphorn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What fraction of cancers are attributed to infections and viruses, according to the article?","Question",{"text":63,"@type":64},"The article estimates that 15%–20% of human cancers are attributable to infections, with 8%–10% caused by viruses.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the genomic profile differ between virus-positive and virus-negative tumors?",{"text":68,"@type":64},"Virus-positive tumors show lower somatic burden, distinct mutation signatures, and driver gene mutations, including fewer TP53 and CDKN2A alterations but more mutations in DDX3X and EIF4A1.",{"name":70,"@type":61,"acceptedAnswer":71},"How is virus positivity associated with response to PD-(L)1 inhibitors?",{"text":72,"@type":64},"Analysis of PD-(L)1 inhibitor clinical trials suggests virus positivity correlates with a higher treatment response rate, most clearly in gastric cancer and head and neck squamous cell carcinoma, along with increased CD8+ T-cell infiltration and TCR clonal selection.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370702,1790379297,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},2336475401981,"https://ap-avatar.wpscdn.com/avatar/22000c94efd8d5204d?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786935347598174694","Article [https://doi.org/10.1038/s41467-025-60836-9](https://doi.org/10.1038/s41467-025-60836-9)  \nGenomic landscape of virus-associated cancers  \nReceived: 8 May 2024  \n\n| Accepted: 5 June 2025 |\n| --- |\n| |\n| Check for updates |\n\nYoonhee Nam 1,9, Karen Gomez1,9, Jean-Baptiste Reynier 1,2, Cole Khamnei1, Michael Aitken1,3, Vivian Zheng 1, Tenzin Lhakhang1, Milena Casula 4, Giuseppe Palmieri 4,5, Antonio Cossu6, Arnold Levine 7, Enrico Tiacci8 & Raul Rabadan 1,2   \nIt has been estimated that 15%-20% of human cancers are attributable to infections, mostly by carcinogenic viruses. The incidence varies worldwide, with a majority affecting developing countries. Here, we conduct a comparative analysis of virus-positive and virus-negative tumors in nine cancers linked to ﬁve viruses. We observe a higher frequency of virus-positive tumors in males, with notable geographic differences in incidence. Our genomic analysis of 1971 tumors reveals a lower somatic burden, distinct mutation signatures, and driver gene mutations in virus-positive tumors. Compared to virusnegative cases, virus-positive cases have fewer mutations of TP53, CDKN2A, and deletions of 9p21.3/CDKN2A-CDKN1A while exhibiting more mutations in RNA helicases DDX3Xand EIF4A1. Furthermore, an analysis of clinical trials of PD-(L)1 inhibitors suggests an association of virus-positivity with higher treatment response rate, particularly evident in gastric cancer and head and neck squamous cell carcinoma. Both cancer types also show evidence of increased CD8 + T cell inﬁltration and T cell receptor clonal selection in viruspositive tumors. These results illustrate the epidemiological, genetic, and therapeutic trends across virus-associated malignancies.  \nAn estimated 15-20% of cancers are attributable to infections1,2, and 8–10% are caused by viruses3,4. To date, seven viruses are known to be associated with the development of cancers in humans (oncoviruses): human gammaherpesvirus 4 (HHV-4, also known as Epstein-Barr virus [EBV]), human herpesvirus 8 (HHV-8), human papillomavirus (HPV), human T-cell lymphotropic virus type 1 (HTLV-1), hepatitis B virus (HBV), hepatitis C virus (HCV), and Merkel cell polyomavirus (MCPyV)5. In addition, previous studies have observed potential associations ofadeno-associated virus 2 (AAV2) with hepatocellular carcinomas (HCC)6, cytomegalovirus (CMV) with glioblastoma multiforme (GBM)7,  \nand a “hit-and-run” mechanism of viral involvement in classical Hodgkin lymphoma (CHL)8.  \nWhile the mechanisms of malignant transformation caused by oncoviruses differ, there are some general patterns that are observed9. First, oncoviruses cause a persistent, long-term infection, and tumors develop years after the initial infection. For example, most individuals are infected with EBV by early childhood (in developing countries) or adolescence (in developed countries)10, but an EBV-associated cancer may not develop until old age. Hepatocellular carcinoma develops 10–30 years after infection with HBV or HCV11, and cervical cancer  \n1Program for Mathematical Genomics and Department of Systems Biology, Columbia University, New York, NY, USA. 2Department of Biomedical Informatics, Columbia University, New York, NY, USA. 3Department of Physics, Columbia University, New York, NY, USA. 4Unit of Cancer Genetics, Institute of Genetic Biomedical Research (IRGB), National Research Council (CNR), Sassari, Italy. 5Immuno-Oncology & Targeted Cancer Biotherapies, University of Sassari, Sassari, Italy. 6Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy. 7Simons Center for Systems Biology, Institute for Advanced Study, Princeton, NJ, USA. 8Institute of Hematology and Center for Hemato-Oncology Research, Department of Medicine and Surgery, University and Hospital of Perugia, Perugia, Italy. 9These authors contributed equally: Yoonhee Nam, Karen Gomez. e-mail: [rr2579@cumc.columbia.edu](rr2579@cumc.columbia.edu)  \ndevelops 25–30 years following i","cbCaiprFqDtL2jBu","https://ap.wps.com/l/cbCaiprFqDtL2jBu","pdf",18403770,16,"English","# Genomic landscape of virus-associated cancers\n## Background: infection-attributable cancers and oncoviruses\n## Study design: comparative analysis across cancer types\n## Genomic findings in virus-positive tumors\n## Clinical relevance: PD-(L)1 response and immune markers","[{\"question\":\"What fraction of cancers are attributed to infections and viruses, according to the article?\",\"answer\":\"The article estimates that 15%–20% of human cancers are attributable to infections, with 8%–10% caused by viruses.\"},{\"question\":\"How does the genomic profile differ between virus-positive and virus-negative tumors?\",\"answer\":\"Virus-positive tumors show lower somatic burden, distinct mutation signatures, and driver gene mutations, including fewer TP53 and CDKN2A alterations but more mutations in DDX3X and EIF4A1.\"},{\"question\":\"How is virus positivity associated with response to PD-(L)1 inhibitors?\",\"answer\":\"Analysis of PD-(L)1 inhibitor clinical trials suggests virus positivity correlates with a higher treatment response rate, most clearly in gastric cancer and head and neck squamous cell carcinoma, along with increased CD8+ T-cell infiltration and TCR clonal selection.\"}]","Genomic landscape of virus-associated cancers | PDF",1790189937,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8e449fbee1aba32a1bea3598b693fe2.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4203a8ac51c45a77d75d8d25a19661c6.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49208c1c83a332177d2001407e219fde.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f9658a23ea4fa9604c7aca8aa8184509.webp",980,1301]